168 related articles for article (PubMed ID: 35974225)
21. Percutaneous coronary intervention outcomes in patients with rheumatoid arthritis, systemic lupus erythematosus and systemic sclerosis.
Martinez SC; Mohamed M; Potts J; Abhishek A; Roddy E; Savage M; Bharadwaj A; Kwok CS; Bagur R; Mamas MA
Rheumatology (Oxford); 2020 Sep; 59(9):2512-2522. PubMed ID: 31990337
[TBL] [Abstract][Full Text] [Related]
22. Exercise-based cardiac rehabilitation for coronary heart disease.
Anderson L; Thompson DR; Oldridge N; Zwisler AD; Rees K; Martin N; Taylor RS
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD001800. PubMed ID: 26730878
[TBL] [Abstract][Full Text] [Related]
23. Outcomes of Percutaneous Coronary Intervention in Patients With Rheumatoid Arthritis.
Dawson LP; Dinh D; O'Brien J; Duffy SJ; Guymer E; Brennan A; Clark D; Oqueli E; Hiew C; Freeman M; Reid CM; Ajani AE;
Am J Cardiol; 2021 Feb; 140():39-46. PubMed ID: 33144158
[TBL] [Abstract][Full Text] [Related]
24. First Hospitalization for Heart Failure in Outpatients With Stable Coronary Artery Disease: Determinants, Role of Incident Myocardial Infarction, and Prognosis.
Lamblin N; Meurice T; Tricot O; de Groote P; Lemesle G; Bauters C
J Card Fail; 2018 Dec; 24(12):815-822. PubMed ID: 30296582
[TBL] [Abstract][Full Text] [Related]
25. Increased hospitalization rates following heart failure diagnosis in rheumatoid arthritis as compared to the general population.
Myasoedova E; Davis JM; Matteson EL; Achenbach SJ; Setoguchi S; Dunlay SM; Roger VL; Gabriel SE; Crowson CS
Semin Arthritis Rheum; 2020 Feb; 50(1):25-29. PubMed ID: 31376995
[TBL] [Abstract][Full Text] [Related]
26. Biologics May Prevent Cardiovascular Events in Rheumatoid Arthritis by Inhibiting Coronary Plaque Formation and Stabilizing High-Risk Lesions.
Karpouzas GA; Ormseth SR; Hernandez E; Budoff MJ
Arthritis Rheumatol; 2020 Sep; 72(9):1467-1475. PubMed ID: 32319221
[TBL] [Abstract][Full Text] [Related]
27. The impact of traditional cardiovascular risk factors on cardiovascular outcomes in patients with rheumatoid arthritis: a systematic review and meta-analysis.
Baghdadi LR; Woodman RJ; Shanahan EM; Mangoni AA
PLoS One; 2015; 10(2):e0117952. PubMed ID: 25689371
[TBL] [Abstract][Full Text] [Related]
28. Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis.
Solomon DH; Avorn J; Katz JN; Weinblatt ME; Setoguchi S; Levin R; Schneeweiss S
Arthritis Rheum; 2006 Dec; 54(12):3790-8. PubMed ID: 17136752
[TBL] [Abstract][Full Text] [Related]
29. Antibiotics for secondary prevention of coronary heart disease.
Sethi NJ; Safi S; Korang SK; Hróbjartsson A; Skoog M; Gluud C; Jakobsen JC
Cochrane Database Syst Rev; 2021 Feb; 2(2):CD003610. PubMed ID: 33704780
[TBL] [Abstract][Full Text] [Related]
30. Cardiovascular events are not associated with MTHFR polymorphisms, but are associated with methotrexate use and traditional risk factors in US veterans with rheumatoid arthritis.
Davis LA; Cannon GW; Pointer LF; Haverhals LM; Wolff RK; Mikuls TR; Reimold AM; Kerr GS; Richards JS; Johnson DS; Valuck R; Prochazka A; Caplan L
J Rheumatol; 2013 Jun; 40(6):809-17. PubMed ID: 23547211
[TBL] [Abstract][Full Text] [Related]
31. Subsequent Cardiovascular Events Among Patients With Rheumatoid Arthritis, Psoriatic Arthritis, or Psoriasis: Patterns of Disease-Modifying Antirheumatic Drug Treatment.
Sparks JA; Lesperance T; Accortt NA; Solomon DH
Arthritis Care Res (Hoboken); 2019 Apr; 71(4):512-520. PubMed ID: 29799667
[TBL] [Abstract][Full Text] [Related]
32. The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years.
Nicola PJ; Maradit-Kremers H; Roger VL; Jacobsen SJ; Crowson CS; Ballman KV; Gabriel SE
Arthritis Rheum; 2005 Feb; 52(2):412-20. PubMed ID: 15692992
[TBL] [Abstract][Full Text] [Related]
33. Low-dose prednisolone treatment of early rheumatoid arthritis and late cardiovascular outcome and survival: 10-year follow-up of a 2-year randomised trial.
Ajeganova S; Svensson B; Hafström I;
BMJ Open; 2014 Apr; 4(4):e004259. PubMed ID: 24710131
[TBL] [Abstract][Full Text] [Related]
34. The influence of rheumatoid arthritis disease characteristics on heart failure.
Myasoedova E; Crowson CS; Nicola PJ; Maradit-Kremers H; Davis JM; Roger VL; Therneau TM; Gabriel SE
J Rheumatol; 2011 Aug; 38(8):1601-6. PubMed ID: 21572155
[TBL] [Abstract][Full Text] [Related]
35. Celecoxib for rheumatoid arthritis.
Fidahic M; Jelicic Kadic A; Radic M; Puljak L
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD012095. PubMed ID: 28597983
[TBL] [Abstract][Full Text] [Related]
36. Increased case fatality rates following a first acute cardiovascular event in patients with rheumatoid arthritis.
Van Doornum S; Brand C; King B; Sundararajan V
Arthritis Rheum; 2006 Jul; 54(7):2061-8. PubMed ID: 16802340
[TBL] [Abstract][Full Text] [Related]
37. Do statins reduce the cardiovascular risk in patients with rheumatoid arthritis?
Danninger K; Hoppe UC; Pieringer H
Int J Rheum Dis; 2014 Jul; 17(6):606-11. PubMed ID: 24931356
[TBL] [Abstract][Full Text] [Related]
38. Perioperative all-cause mortality and cardiovascular events in patients with rheumatoid arthritis: comparison with unaffected controls and persons with diabetes mellitus.
Yazdanyar A; Wasko MC; Kraemer KL; Ward MM
Arthritis Rheum; 2012 Aug; 64(8):2429-37. PubMed ID: 22354534
[TBL] [Abstract][Full Text] [Related]
39. The heart in rheumatoid arthritis.
Turiel M; Sitia S; Atzeni F; Tomasoni L; Gianturco L; Giuffrida M; De Gennaro Colonna V; Sarzi-Puttini P
Autoimmun Rev; 2010 Apr; 9(6):414-8. PubMed ID: 19913641
[TBL] [Abstract][Full Text] [Related]
40. The role of rheumatologists vis-à-vis assessment of traditional cardiovascular risk factors in rheumatoid arthritis.
Luck Y; Baron M; Bardakjian S; Berkson L; Buchignani M; Fallavolita S; Giac F; Gyger G; Tatibouet S; Hudson M
Clin Rheumatol; 2014 Jun; 33(6):769-74. PubMed ID: 24526251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
